Civica
Financial intelligence for Asia's healthcare markets
 
 
Remember me:

Analysis: Quadria boosts Asian investments

Singapore-based private equity firm Quadria Capital is expanding its holdings in the region with investments into Vietnam and Singapore from its third investment vehicle, Quadria Capital Fund. Financial details were not disclosed for either transaction.

In Vietnam, it has completed an investment in HCM City-based FV Hospital. Founded by Jean-Marcel Guillon in 2003, the 220-bed hospital has more than 950 service staff, including 130 Vietnamese and expatriate doctors. It is the only joint commission international accredited hospital in South Vietnam. It also operates an outpatient clinic at the heart of District 1, HCM City’s traditional business district.

The investment will be used to build leading diagnostic and treatment centres for selected specialties and to provide access to advanced care in Central and South Vietnam via establishing an integrated network of healthcare facilities across the region.

Other investors who participated in the investment with Quadria include funds managed by Neuberger Berman Private Equity and DEG, the German development finance institution and a subsidiary of KfW.

In Singapore, it has taken a significant stake in MWH Holdings, the holding company for the Singapore Heart, Stroke and Cancer Centre. MWH currently operates out of Paragon Medical Centre and will be expanding its operations this year with a new centre located at Royal Square Novena.

It currently operates under four flagship brands: Singapore Heart, Stroke and Cancer Centre, a specialist centre focused on prevention, early diagnosis and treatment of heart disease, stroke and cancer; Singapore Medical Specialists Centre – multi-specialist centre offering a comprehensive range of specialty care services; Singapore Centre for Medical Imaging, a radiology centre offering a wide range of latest high-end diagnostics modalities; and Face, Body and Skin Aesthetics Medical Center, an aesthetics centre offering non-invasive, minimally invasive and surgical proceedures.

“Whilst we continue to serve the domestic and medical tourism segment out of Singapore, we see a significant opportunity regionally, particularly in the mid-tier segment where patients require something more affordable or for certain conditions where patients are unable to travel for treatment,” said Michael Lim, chief medical officer of MWH. And Quadria will support MWH’s regional growth ambitions through its existing hospital network and relationships.

Quadria Capital has assets exceeding US$1.5 billion and investments in 15 companies across the AsiaPacific region. It closed its third Quadria Capital Fund at US$304 million in June 2015 with two investments in Medica Synergie, the largest hospital network in eastern India, and SOHO Global Health, one of the largest pharmaceutical manufacturing and distribution businesses in Indonesia. The investments in Vietnam and Singapore are the sixth and seventh investments from that fund.

Posted on: 12/07/2017 UTC+08:00


News

Shares in Sisram Medical, a Israeli subsidiary of Shanghai Fosun Pharmaceutical, and which manufactures medical aesthetics devices, slumped on their Hong Kong Stock Exchange debut today. By late morning they were down more than 6%.
Auckland-based ehealth software company Orion Health has signed a five-year contract with Integrated Health Information Systems (IHiS), the health technology agency for Singapore.
Irish healthcare, IT and services company Clanwilliam Group has taken a majority shareholding in HealthLink, Australasia’s leading health-system integrator. Financial terms have not been disclosed.
Strategic initiatives and expansion have driven a rise in first quarter profits at iKang Healthcare Group, China’s largest private preventive healthcare services provider.
Optiscan Imaging, which develops microscopic imaging technologies for medical markets, has announced an exclusive distribution agreement with Chinese based China Gate Scientific for the newest Optiscan preclinical research system, ViewnVivo.
Contract genomics organisation WuXi NextCODE has appointed Rob Brainin as executive vice president and chief operating officer. Brainin joins the company from Illumina, where he was vice president and general manager of life sciences and applied genomics.
Melbourne-based medtech company Novita Healthcare has appointed Bruce Higgins as chairman. He is an experienced non- executive director, chairman and former chief executive of both private and listed companies within Australia and internationally, spanning over 25 years in diverse companies ranging from engineering, manufacturing and professional services to larger contracting businesses.
In what is another setback for Perth-based digital healthcare operator Resapp, Médecins Sans Frontières/Doctors Without Borders has decided not proceed with its planned field evaluation of the group’s software. ResApp’s main product is a cough-based diagnostic test that works with a smartphone to analyse the sound of a patient’s cough and to diagnose any underlying conditions.



Analysis

By 2042 there will be more over-65s in Asia than the populations of the Eurozone and North America combined. We look at the business opportunities this creates.
Albert Wong argues that biomedical technology should not be ignored and explains how the Hong Kong Science and Technology Parks Corporation can support it.
Jacob Pope explains why medical tourism remains one of the region’s most significant industries.
APACMed’s Fredrik Nyberg looks at how local and multinational IVD companies are developing novel solutions for Asia’s unique needs.
It is perhaps a curious line in the sand to draw, but the new hospital in Dunedin, the second-largest city in the South Island of New Zealand, is gearing up to be a significant battle in the use of private-public partnership funding in the APAC region.
The ADB’s Eduardo Banzon argues that ASEAN countries need to guarantee the same health coverage for citizens when they are in foreign countries.
Mercer’s Catherine Li explains how companies in China can avoid common pitfalls when they establish employee health management programmes.
Lieven Jacquemyn, PPP international development director at GE Healthcare Singapore, discusses how governments, providers and investors can work together to bring universal health coverage to the region.


Civica

HealthInvestor Asia Summit

AON

Podcasts

Hedge Fund Focus

HealthInvestor Asia twitter feed
HIA Indices